| |
|
|
|
Aerpio Pharmaceuticals Inc.  
|
|
2.775 -0.135 (-0.05%) |
01-17 09:42 |
|
Open: |
2.9 |
Pre close: |
2.91 |
Target:
|
3.62
|
|
High: |
2.92 |
Low: |
2.775 |
Resistance:
|
3.10
3.62
|
|
Volume: |
505 |
Market Cap: |
113M |
Support:
|
2.15
1.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.82
 |
MACD |
MACD(12,26):
|
0.24 |
|
MA(20): |
2.14 |
Signal(12,26,9): |
0.12 |
|
MA(100): |
2.51  |
Stochastic Oscillator |
%K(14,3):
|
86.80 |
|
MA(250): |
3.53 |
%D(3): |
87.36 |
|
Average Volume(K) |
3-Month: |
7675
|
52-Week |
High:
|
5.25 |
|
10-Days: |
9847 |
Low: |
1.56 |
|
RSI |
RSI(14):
|
74.36 |
Change(%): |
-37.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-18.0 |
Shares Out. (M) |
40.59 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-16.9 |
Shares Float (M) |
40.31 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
29.50 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.460 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.99 |
|
Profit Margin |
-9.32 |
Operating Cash Flow
(M) |
-4.24 |
P/S |
178920928.00 |
|
Operating Margin |
-42.69 |
Levered Free Cash Flow
(M) |
-1.53 |
P/CF |
-27.86 |
|
|
|
|
|
|
